Get the Stockscreener App
24.73
1.23%
0.30
After Hours:
24.95
0.22
+0.89%
Staar Surgical Co stock is traded at $24.73, with a volume of 782.83K.
It is up +1.23% in the last 24 hours and up +31.26% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
See More
Previous Close:
$24.43
Open:
$24.49
24h Volume:
782.83K
Relative Volume:
0.54
Market Cap:
$1.22B
Revenue:
$239.44M
Net Income/Loss:
$-80.45M
P/E Ratio:
-15.17
EPS:
-1.6303
Net Cash Flow:
$-40.05M
1W Performance:
+18.44%
1M Performance:
+31.26%
6M Performance:
-4.15%
1Y Performance:
+49.70%
1-Day Range:
$24.21
$24.74
1-Week Range:
$24.10
$26.92
52-Week Range:
$15.59
$30.81
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
24.73 | 1.21B | 239.44M | -80.45M | -40.05M | -1.6303 |
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-26 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-03-26 | Initiated | Wedbush | Neutral |
| Jan-16-26 | Resumed | Morgan Stanley | Underweight |
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
STAAR Surgical (STAA) Is Up 15.8% After Q1 Revenue More Than DoublesHas The Bull Case Changed? - simplywall.st
Staar Surgical Co (STAA) Shares Fall 9.1% -- What GF Score of 78 Tells Investors - GuruFocus
STAAR Surgical Company (NASDAQ:STAA) Q4 2025 earnings call transcript - MSN
Midday Stock Roundup: Karman Holdings Up 6.7% on Monday - Orange County Business Journal
FDA Expands Age Indication for STAAR Surgical’s EVO ICL - Medical Product Outsourcing
Why Did STAA Stock Surge More Than 19% After-Hours Today? - Stocktwits
A Look at Staar Surgical Co (STAA) After 5.0% Gain -- GF Value $28.53 vs Price $26.44 - GuruFocus
Why did STAA stock surge more than 19% after-hours today? - MSN
STAA Surges More Than 20%, Is It Still a Good Buy Now? - TradingKey
STAAR Surgical surges as Canaccord Genuity raises to buy on Q1 sales - MSN
STAAR Surgical (STAA) Surges on Strong Q1 Sales and Upgrade - GuruFocus
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
STAA Upgraded to 'Buy' by Canaccord Genuity with Raised Price Ta - GuruFocus
These Stocks Are Today's Movers: CoreWeave, BlackBerry, Marvell, Chevron, Neogen, Staar Surgical, and More -- Barrons.com - Moomoo
STAAR Surgical: Q1 Preliminary Revenues Justify Decision To Reject Alcon Bid (NASDAQ:STAA) - Seeking Alpha
Stifel reiterates Hold on STAAR Surgical stock, $18 target By Investing.com - Investing.com Australia
Stifel reiterates Hold on STAAR Surgical stock, $18 target - Investing.com
Needham maintains Hold on STAAR Surgical stock after guidance beat By Investing.com - Investing.com Australia
STAAR Surgical (STAA) Surges on Strong Sales Guidance - GuruFocus
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why did STAAR Surgical (STAA) stock jump 20% after hours? - MSN
Needham maintains Hold on STAAR Surgical stock after guidance beat - Investing.com
Wedbush Raises Price Target on STAAR Surgical to $26 From $21, Keeps Neutral Rating - marketscreener.com
STAAR Surgical soars after company reported preliminary sales that crushed expectations - Sherwood News
STAAR Surgical (STAA) Is Up 8.0% After Q1 2026 Sales More Than DoubleWhat's Changed - Yahoo Finance
Biggest stock movers Thursday: APLD, STAA, and more - MSN
Why Did STAAR Surgical (STAA) Stock Jump 20% After Hours? - Benzinga
STAAR Surgical Reports Over $90 Million in Q1 2026 Net Sales Driven by Strong China Growth - Minichart
STAAR Surgical Issues Preliminary First Quarter Net Sales for 2026 - VisionMonday.com
STAAR Surgical stock surges 18% on strong Q1 sales beat By Investing.com - Investing.com South Africa
Staar Surgical Shares Surge on Expected 1Q Sales Growth - 富途牛牛
After-hours movers: Constellation Brands, Applied Digital, STAAR Surgical, New Era Energy & Digital By Investing.com - Investing.com South Africa
STAAR Surgical Q1 sales top $90M, more than double year ago - Investing.com Australia
STAAR Surgical Company (STAA) Stock Forecasts - Yahoo Finance
Staar Surgical Up 21% on Preliminary Q1 Sales - Orange County Business Journal
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Staar Surgical (STAA) Surges 18% Following Positive Q1 Pre-Annou - GuruFocus
After-hours movers: Constellation Brands, Applied Digital, STAAR Surgical, New Era Energy & Digital - Investing.com Canada
Strong Sales Growth in China Boosts STAA Earnings Outlook - GuruFocus
STAAR Surgical announces preliminary net sales for first quarter 2026 - MSN
Staar Surgical sees Q1 revenue above $90M, consensus $67.6M - TipRanks
STAAR Surgical stock surges 18% on strong Q1 sales beat - Investing.com UK
STAAR Surgical posts Q1 preliminary net sales above $90M, more than double prior year - TradingView — Track All Markets
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Staar Surgical Co Stock (STAA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Foust Warren | Interim Co-CEO and Pres. & COO |
Mar 12 '26 |
Option Exercise |
0.00 |
8,175 |
0 |
34,263 |
| Michna Magda | Chief Development Officer |
Mar 14 '26 |
Option Exercise |
0.00 |
17,595 |
0 |
36,001 |
| Michna Magda | Chief Development Officer |
Mar 12 '26 |
Option Exercise |
0.00 |
6,178 |
0 |
20,622 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 13 '26 |
Buy |
18.61 |
316,017 |
5,882,656 |
16,123,842 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 12 '26 |
Buy |
18.12 |
299,432 |
5,424,330 |
15,807,825 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 11 '26 |
Buy |
17.52 |
54,764 |
959,558 |
15,508,393 |
| Jiang Wei | Director |
Jan 12 '26 |
Option Exercise |
0.00 |
20,967 |
0 |
66,444 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Jan 09 '26 |
Buy |
22.05 |
27,485 |
606,138 |
15,453,629 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Jan 06 '26 |
Buy |
21.62 |
336,946 |
7,284,281 |
15,356,437 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Jan 07 '26 |
Buy |
22.00 |
66,467 |
1,462,301 |
15,422,904 |
0.06%
1.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):